AVITA Therapeutics is a regenerative medicine company with a technology platform to address unmet medical needs in burns, chronic wounds and aesthetics indications. Treatment solutions are derived from the regenerative properties of a patient’s own skin. RECELL is the company’s flagship product. In basic terms, RECELL can be used by doctors to ‘respray’ skin cells onto a patient suffering from some type of injury (e.g. a burn). The product takes a small amount of the patient’s skin as a sample and in around 30 minutes a spray can be created and applied.
The Avita (ASX:AVH) share price is down more than 1% after providing an update for FY20.
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently up 0.01% at lunch.
The AVITA Medical (ASX:AVH) share price is up more than 7.5% this morning after making an announcement.
